Gerresheimer enlarged a cleanroom, installed a high-performance furnace, and automated testing and packaging systems for pharmaceutical glass packaging in Essen, Germany.
Gerresheimer completed a modernization of its plant in Essen, Germany, including renovation of its clear-glass furnace used to produce glass containers for the pharmaceutical industry, the company announced in an Oct. 28, 2019 press release. The improved furnace technology is more powerful but uses less energy, making it more sustainable than its predecessor. The high-performance furnace also adds new capacity for the production of injection and infusion bottles from type II glass for parenteral solutions.
“We want to make production more environmentally friendly while remaining an efficient partner for our customers,” said Dr. Jürgen Unruh, CEO of Gerresheimer Essen, in the release.
According to the release, Gerresheimer is using the renovation as an opportunity to fundamentally modernize the plant. The production hall and cleanroom will be enlarged, and the testing and packaging technology will be further automated. The energy efficiency of the new white glass tank will be improved while at the same time reducing specific carbon dioxide emissions. In addition, a new candle filter sustainably reduces nitrogen oxide content.
The company’s plant in Essen serves as a center of excellence for the production of type II glass. The Gerresheimer Group has production sites for molded glass in Europe, the Americas, and Asia. Three of these are German sites based in Essen, Lohr, and Tettau.
Source: Gerresheimer
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.